203 related articles for article (PubMed ID: 29350712)
21. Surveillance snapshot: Human papillomavirus vaccination among U.S. active component service members in the Millennium Cohort Study, 2006-2017.
Matsuno RK; Porter B; Warner S; Wells N;
MSMR; 2019 Jun; 26(6):18. PubMed ID: 31237764
[No Abstract] [Full Text] [Related]
22. Committee Opinion No. 704: Human Papillomavirus Vaccination.
Obstet Gynecol; 2017 Jun; 129(6):1. PubMed ID: 28346275
[TBL] [Abstract][Full Text] [Related]
23. Committee Opinion No. 704 Summary: Human Papillomavirus Vaccination.
Obstet Gynecol; 2017 Jun; 129(6):1. PubMed ID: 28538494
[TBL] [Abstract][Full Text] [Related]
24. Human Papillomavirus Vaccination Before 13 and 15 Years of Age: Analysis of National Immunization Survey Teen Data.
Bednarczyk RA; Ellingson MK; Omer SB
J Infect Dis; 2019 Jul; 220(5):730-734. PubMed ID: 30657920
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus vaccine in adolescent women: a 2012 update.
Etter DJ; Zimet GD; Rickert VI
Curr Opin Obstet Gynecol; 2012 Oct; 24(5):305-10. PubMed ID: 22781077
[TBL] [Abstract][Full Text] [Related]
26. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
Vetter KM; Geller SE
J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
[TBL] [Abstract][Full Text] [Related]
27. Human Papillomavirus Vaccination Coverage Among Girls Before 13 Years: A Birth Year Cohort Analysis of the National Immunization Survey-Teen, 2008-2013.
Jeyarajah J; Elam-Evans LD; Stokley S; Smith PJ; Singleton JA
Clin Pediatr (Phila); 2016 Sep; 55(10):904-14. PubMed ID: 26603581
[TBL] [Abstract][Full Text] [Related]
28. The effects of a brief educational intervention on human papillomavirus knowledge and intention to initiate HPV vaccination in 18-26 year old young adults.
Kester LM; Shedd-Steele RB; Dotson-Roberts CA; Smith J; Zimet GD
Gynecol Oncol; 2014 Mar; 132 Suppl 1():S9-12. PubMed ID: 24384459
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus vaccination in commercially-insured vaccine-eligible males and females, United States, 2007-2014.
Gargano JW; Zhou F; Stokley S; Markowitz LE
Vaccine; 2018 May; 36(23):3381-3386. PubMed ID: 29735321
[TBL] [Abstract][Full Text] [Related]
30. Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(50):1705-8. PubMed ID: 22189893
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus vaccine: recommendations, issues and controversies.
Fisher R; Darrow DH; Tranter M; Williams JV
Curr Opin Pediatr; 2008 Aug; 20(4):441-5. PubMed ID: 18622201
[TBL] [Abstract][Full Text] [Related]
32. Human Papillomavirus Vaccine Uptake: Increase for American Indian Adolescents, 2013-2015.
Jacobs-Wingo JL; Jim CC; Groom AV
Am J Prev Med; 2017 Aug; 53(2):162-168. PubMed ID: 28256284
[TBL] [Abstract][Full Text] [Related]
33. Uptake of human papillomavirus vaccine among adolescent males and females: Immunization Information System sentinel sites, 2009-2012.
Cullen KA; Stokley S; Markowitz LE
Acad Pediatr; 2014; 14(5):497-504. PubMed ID: 24954170
[TBL] [Abstract][Full Text] [Related]
34. Trends and predictors of HPV vaccination among U.S. College women and men.
Thompson EL; Vamos CA; Vázquez-Otero C; Logan R; Griner S; Daley EM
Prev Med; 2016 May; 86():92-8. PubMed ID: 26868093
[TBL] [Abstract][Full Text] [Related]
35. Physicians' human papillomavirus vaccine recommendations in the context of permissive guidelines for male patients: a national study.
Malo TL; Giuliano AR; Kahn JA; Zimet GD; Lee JH; Zhao X; Vadaparampil ST
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):2126-35. PubMed ID: 25028456
[TBL] [Abstract][Full Text] [Related]
36. Promoting HPV prevention in the school setting.
Bellia-Weiss T; Parsons M; Sebach AM; Rockelli LA
NASN Sch Nurse; 2013 Mar; 28(2):86-93. PubMed ID: 23600092
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence and seroincidence of herpes simplex virus (2006-2010), syphilis (2006-2010), and vaccine-preventable human papillomavirus subtypes (2000-2010) among US military personnel.
Masel J; Deiss RG; Wang X; Sanchez JL; Ganesan A; Macalino GE; Gaydos JC; Kortepeter MG; Agan BK
Sex Transm Dis; 2015 May; 42(5):253-8. PubMed ID: 25868137
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus vaccine uptake among males 11-26 years in United States: findings from the National Health and Nutrition Examination Survey, 2011-2012.
Pierre-Victor D; Mukherjee S; Bahelah R; Madhivanan P
Vaccine; 2014 Nov; 32(49):6655-8. PubMed ID: 25446825
[TBL] [Abstract][Full Text] [Related]
39. Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.
Pathela P; Jamison K; Papadouka V; Kabir R; Markowitz LE; Dunne EF; Schillinger JA
J Adolesc Health; 2016 Dec; 59(6):710-715. PubMed ID: 27671357
[TBL] [Abstract][Full Text] [Related]
40. Human Papillomavirus and Mandatory Immunization Laws: What Can We Learn From Early Mandates?
Barraza L; Weidenaar K; Campos-Outcalt D; Yang YT
Public Health Rep; 2016 Sep; 131(5):728-731. PubMed ID: 28123214
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
